159 related articles for article (PubMed ID: 36405943)
21. The Human Papillomavirus as a Common Pathogen in Oropharyngeal, Anal and Cervical Cancers.
Otter S; Whitaker S; Chatterjee J; Stewart A
Clin Oncol (R Coll Radiol); 2019 Feb; 31(2):81-90. PubMed ID: 30385006
[TBL] [Abstract][Full Text] [Related]
22. Trends in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma Incidence, Vermont 1999-2013.
Owosho AA; Wiley R; Stansbury T; Gbadamosi SO; Ryder JS
J Community Health; 2018 Aug; 43(4):731-737. PubMed ID: 29427129
[TBL] [Abstract][Full Text] [Related]
23. Human Papillomavirus-Associated Cancers - United States, 2008-2012.
Viens LJ; Henley SJ; Watson M; Markowitz LE; Thomas CC; Thompson TD; Razzaghi H; Saraiya M
MMWR Morb Mortal Wkly Rep; 2016 Jul; 65(26):661-6. PubMed ID: 27387669
[TBL] [Abstract][Full Text] [Related]
24. Burden of cancers in India - estimates of cancer crude incidence, YLLs, YLDs and DALYs for 2021 and 2025 based on National Cancer Registry Program.
Kulothungan V; Sathishkumar K; Leburu S; Ramamoorthy T; Stephen S; Basavarajappa D; Tomy N; Mohan R; Menon GR; Mathur P
BMC Cancer; 2022 May; 22(1):527. PubMed ID: 35546232
[TBL] [Abstract][Full Text] [Related]
25. The burden of human papillomavirus infections and related diseases in sub-saharan Africa.
De Vuyst H; Alemany L; Lacey C; Chibwesha CJ; Sahasrabuddhe V; Banura C; Denny L; Parham GP
Vaccine; 2013 Dec; 31 Suppl 5(0 5):F32-46. PubMed ID: 24331746
[TBL] [Abstract][Full Text] [Related]
26. Cancer attributable to human papillomavirus infection in China: Burden and trends.
Lu Y; Li P; Luo G; Liu D; Zou H
Cancer; 2020 Aug; 126(16):3719-3732. PubMed ID: 32484937
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage.
Võrno T; Lutsar K; Uusküla A; Padrik L; Raud T; Reile R; Nahkur O; Kiivet RA
Vaccine; 2017 Nov; 35(46):6329-6335. PubMed ID: 28899625
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology and incidence of HPV-related cancers of the head and neck.
Roman BR; Aragones A
J Surg Oncol; 2021 Nov; 124(6):920-922. PubMed ID: 34558067
[TBL] [Abstract][Full Text] [Related]
29. Human Papillomavirus-Attributable Cancers - United States, 2012-2016.
Senkomago V; Henley SJ; Thomas CC; Mix JM; Markowitz LE; Saraiya M
MMWR Morb Mortal Wkly Rep; 2019 Aug; 68(33):724-728. PubMed ID: 31437140
[TBL] [Abstract][Full Text] [Related]
30. Global burden of human papillomavirus and related diseases.
Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
[TBL] [Abstract][Full Text] [Related]
31. The healthcare costs of treating human papillomavirus-related cancers in Norway.
Hylin H; Thrane H; Pedersen K; Kristiansen IS; Burger EA
BMC Cancer; 2019 May; 19(1):426. PubMed ID: 31064346
[TBL] [Abstract][Full Text] [Related]
32. Do cervical cancer data justify HPV vaccination in India? Epidemiological data sources and comprehensiveness.
Mattheij I; Pollock AM; Brhlikova P
J R Soc Med; 2012 Jun; 105(6):250-62. PubMed ID: 22722970
[TBL] [Abstract][Full Text] [Related]
33. Trends in breast and cervical cancer in India under National Cancer Registry Programme: An Age-Period-Cohort analysis.
Sathishkumar K; N V; Badwe RA; Deo SVS; Manoharan N; Malik R; Panse NS; Ramesh C; Shrivastava A; Swaminathan R; Vijay CR; Narasimhan S; Chaturvedi M; Mathur P
Cancer Epidemiol; 2021 Oct; 74():101982. PubMed ID: 34280846
[TBL] [Abstract][Full Text] [Related]
34. Long-term incidence trends of HPV-related cancers, and cases preventable by HPV vaccination: a registry-based study in Norway.
Hansen BT; Campbell S; Nygård M
BMJ Open; 2018 Feb; 8(2):e019005. PubMed ID: 29476028
[TBL] [Abstract][Full Text] [Related]
35. Beyond cervical cancer: burden of other HPV-related cancers among men and women.
Chaturvedi AK
J Adolesc Health; 2010 Apr; 46(4 Suppl):S20-6. PubMed ID: 20307840
[TBL] [Abstract][Full Text] [Related]
36. Spatial patterns of human papillomavirus-associated cancers within the state of Minnesota, 1998-2007.
Nelson EJ; Hughes J; Kulasingam SL
Spat Spatiotemporal Epidemiol; 2014 Jun; 9():13-21. PubMed ID: 24889990
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.
Barnabas RV; Laukkanen P; Koskela P; Kontula O; Lehtinen M; Garnett GP
PLoS Med; 2006 May; 3(5):e138. PubMed ID: 16573364
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive control of human papillomavirus infections and related diseases.
Bosch FX; Broker TR; Forman D; Moscicki AB; Gillison ML; Doorbar J; Stern PL; Stanley M; Arbyn M; Poljak M; Cuzick J; Castle PE; Schiller JT; Markowitz LE; Fisher WA; Canfell K; Denny LA; Franco EL; Steben M; Kane MA; Schiffman M; Meijer CJ; Sankaranarayanan R; Castellsagué X; Kim JJ; Brotons M; Alemany L; Albero G; Diaz M; de Sanjosé S;
Vaccine; 2013 Dec; 31 Suppl 5():F1-31. PubMed ID: 24331745
[TBL] [Abstract][Full Text] [Related]
39. The projected timeframe until cervical cancer elimination in Australia: a modelling study.
Hall MT; Simms KT; Lew JB; Smith MA; Brotherton JM; Saville M; Frazer IH; Canfell K
Lancet Public Health; 2019 Jan; 4(1):e19-e27. PubMed ID: 30291040
[TBL] [Abstract][Full Text] [Related]
40. The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?
Patel C; Brotherton JM; Pillsbury A; Jayasinghe S; Donovan B; Macartney K; Marshall H
Euro Surveill; 2018 Oct; 23(41):. PubMed ID: 30326995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
